QSimulate
About
QSimulate develops quantum-powered simulation solutions that significantly reduce drug discovery timelines by applying advanced quantum mechanics to molecular simulations. Their platform, QUELO, is designed for peptide drug discovery and other complex molecular interactions, enabling faster and more accurate predictions.
Key facts
At-a-glance profile data
- Website
- qsimulate.com
- Headquarters
- Boston, United States
- Founded
- 2018
- Total funding
- $14M (Seed)
- Business model
- B2B
Funding rounds
Tech stack
Detected on qsimulate.com, last scanned 6 Sept 2026. Run your own scan
- Hosting
- AWS
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has QSimulate raised?
QSimulate has raised a total of $14M in funding. The most recent round on record is Seed.